Stock Movers: Delta Pulls Guidance, Pharma Stocks Decline, Walmart Rises

Delta's Guidance Withdrawal

• ✈️ Delta Air Lines is trading higher despite withdrawing its full-year guidance, citing stalled growth and current uncertainty.
• 💡 The market's positive reaction is seen as non-traditional, driven by first-quarter numbers that are reportedly in line with expectations.

Pharmaceutical Stock Downturn

• 💊 Pharmaceutical stocks are experiencing a significant downturn, with companies like AbbVie (ABBV), Abbott (ABT), Gilead Sciences (GILD), Bristol Myers Squib (BMY), and Pfizer (PFE) all seeing notable declines.
• 📉 This broad market hit is attributed to proposed tariffs by President Trump on the pharma industry, impacting both US and European companies like Novo Nordisk, Roche, and Sanofi.
• ⚠️ The sell-off in pharmaceutical bonds is also a contributing factor, with credit market movements magnifying the impact on equity prices.

Walmart's Positive Outlook

• 🛒 Walmart shares are trading higher as the CEO emphasizes a focus on cost-cutting measures and maintaining low prices.
• 📈 The company is reaffirming its first-quarter sales guidance and its full-year 2026 guidance remains unchanged, indicating continued net sales growth of 3% to 4% this year.

Market Overview

• 📊 The overall market is described as a choppy pre-market session, with significant stock movements at the micro level.
• 🎧 This episode of Stock Movers provides a roundup of companies making significant moves in the stock market, leveraging Bloomberg data for analysis.